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Introduction
53BP1, identifi  ed as a p53-interacting protein, is involved in 
DNA damage–induced checkpoint arrest. After ionizing radia-
tion (IR) treatment, 53BP1 becomes progressively, yet tran-
siently, immobilized around the double-strand break–fl  anking 
chromatin (Bekker-Jensen et al., 2005). 53BP1 contains a 
381-amino-acid region (1235–1616), called the kinetochore 
binding domain, which is essential for the accumulation of IR-
induced 53BP1 foci (Morales et al., 2003). Methylated lysine 
residues in the kinetochore binding domain modulate the acces-
sibility of 53BP1 to the chromatin (Huyen et al., 2004; Botuyan 
et al., 2006). 53BP1 foci have also been detected in response to 
UV radiation, hydroxyurea (HU), camptothecin, and etoposide 
treatment (Rappold et al., 2001). We have recently shown that 
53BP1 is involved in the recruitment of two important caretaker 
tumor suppressors, BLM and p53, to the sites of HU-induced 
stalled replication forks in S-phase (Sengupta et al., 2004). 
  Incidentally, like p53 and BLM, 53BP1 also displays a “hyper-
rec” phenotype (Adams et al., 2005). Hence, 53BP1 may lead 
to aberrant recognition of the stalled replication forks, resulting 
in chromosomal abnormalities, as observed in p53
−/−53BP1
−/− 
mice (Ward et al., 2005; Morales et al., 2006).
BLM helicase has been proposed to function at the interface 
of replication and recombination and facilitate the repair of dam-
aged DNA (Hickson, 2003). The major characteristic of BLM 
patients is elevated recombination events. BLM may regulate 
homologous recombination (HR) by modulating the functions of 
other proteins involved in the process. BLM resides in a nuclear 
matrix bound complex with prorecombinogenic protein RAD51 
(Bischof et al., 2001). The direct interaction between BLM and 
RAD51 is evolutionarily conserved and has been proposed to 
have a role during recombinational repair. The focal expression 
of BLM and RAD51 has an inverse correlation in human cells 
(Wu et al., 2001). Exposure of cells to replication stress and IR 
causes BLM to colocalize and physically interact with RAD51 
at the sites of DNA damage (Wu et al., 2001; Sengupta et al., 
2003). Inactivation of p53 in Bloom syndrome (BS) cells causes 
a further increase of sister chromatid exchange (SCE), thereby 
demonstrating that p53 and BLM cooperatively affect HR 
(Sengupta et al., 2003). Because BLM and 53BP1 have the po-
tential to be functionally involved during replication stress, we 
sought to investigate whether and, if so, how these two proteins 
can affect HR by modulating the functions of RAD51.
Results and discussion
To determine whether 53BP1 interacts with BLM and RAD51 
during replication stress, we performed reciprocal immunoprecip-
itation (IP; Fig. 1, B–D) experiments on human telomerase 
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reverse transcriptase (hTERT)–immortalized normal human 
fi  broblasts (NHFs), left asynchronous (−HU), arrested in S-phase 
by HU (+HU), or allowed to proceed after washing away HU 
(postwash; Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200610051/DC1). 53BP1 and RAD51 protein levels in 
the nuclear extract (whose integrity was verifi  ed; Fig. S1 B) 
remained unchanged in −HU, +HU, or postwash conditions. 
In contrast, BLM accumulated during +HU treatment, and the 
protein levels remained high during the postwash stage (Fig. 1 A). 
Importantly, both 53BP1 and RAD51 were present in the BLM 
IPs only during HU treatment (Fig. 1 B). IPs with 53BP1 (Fig. 1 C) 
and RAD51 (Fig. 1 D) antibodies confi  rmed the formation of a 
complex where BLM, 53BP1, and RAD51 were present. How-
ever, these results do not rule out the concurrent presence of 
53BP1–RAD51 and BLM–RAD51 complexes during +HU con-
dition. Low levels of 53BP1–RAD51 interactions also occurred 
during –HU and postwash conditions (Fig. 1, C and D).
Because both 53BP1 and BLM interact with RAD51, 
there is a possibility that both of these proteins play a role in 
controlling HR and subsequent cell survival. To determine 
whether loss of 53BP1 alone could indeed cause a change in 
cell survival after stalling of the replication forks, embryonic 
stem cells from 53BP1
+/+ and 53BP1
−/− mice were used (Ward 
et al., 2003; Fig. 2 A, inset). A substantial increase in sensitivity 
to HU was observed in 53BP1
−/− cells during clonogenic sur-
vival assays (Fig. 2 A), which may be due to increased chromo-
somal instability. To confi  rm this hypothesis, metaphase spreads 
were analyzed from asynchronous or HU-treated 53BP1
+/+ and 
53BP1
−/− cells (Table I). A statistically signifi  cant increase in 
the number of chromosomal aberrations was observed in HU-
treated 53BP1
−/− cells, consistent with the possibility that 53BP1 
is required in the regulation of chromosomal instability and cell 
survival during replication arrest.
A role for 53BP1 in controlling genomic integrity and 
cell survival during S-phase may be due to its effect on HR. 
A role for 53BP1 in suppressing HR has been recently indicated 
(Adams et al., 2005). It has also been reported that although 
spontaneous HR by gene conversion did not depend on 53BP1, 
class switch recombination was severely impaired by lack of 
53BP1 (Ward et al., 2004). However, the effect of 53BP1 on 
stress-induced HR has never been addressed. The effect of 53BP1 
alone on HR was measured by SCE assays in 53BP1
+/+ and 
53BP1
−/− cells. Loss of 53BP1 resulted in a statistically signifi  cant 
Figure 1.  53BP1 interacts with BLM and RAD51 during replication stress. 
(A) Levels of 53BP1, BLM, and RAD51 in nuclear extracts from NHFs. Nu-
clear extracts were prepared from NHFs grown in the absence or presence 
of HU and after postwash (PW). Western blots were performed with anti-
53BP1, anti-BLM, anti-RAD51, and anti-TBP antibodies. (B–D) BLM, RAD51, 
and 53BP1 are present in the same complex during replication stress. Re-
ciprocal IPs with nuclear extracts were performed with anti-BLM (B), anti-
53BP1 (C), and anti-RAD51 (D) antibodies and the corresponding IgGs. 
The IPs were probed with self-antibody or with antibodies against BLM, 
53BP1, and RAD51 to check for interactions.
Figure 2.  53BP1 regulates chromosomal stability and HR. (A) 53BP1
−/− 
cells are hypersensitive to HU. Clonogenic survival analysis was performed 
in 5BP1
+/+ (squares) and 53BP
−/− (diamonds) cells. Error bars represent 
SEMs. (B) Absence of 53BP1 enhances SCE. SCE measurements (mean ± 
SD) were performed in 53BP1
+/+ and BS 53BP1
−/− embryonic stem cells 
in the absence (−HU) or presence (+HU) of replication arrest. The p-values 
were obtained by t test. (C) Overexpression of 53BP1 decreases HR. NHF, 
BS, and A-15 cells were used for experiment. pBHRF was either transfected 
alone or cotransfected with other expression vectors, as indicated. After 
transfection and before harvesting, the cells were treated with HU for 16 h. 
Cells were subsequently analyzed using a ﬂ  ow cytometer. The fold difference 
of the GFP/BFP ratio is represented.53BP1 AND BLM EFFECT ON RECOMBINATION • TRIPATHI ET AL. 11
increase in SCE level during replication stress (Fig. 2 B), indi-
cating that 53BP1 has an antirecombinogenic effect on HR dur-
ing replication stress.
The antirecombinogenic effect of 53BP1 was sub  sequently 
verifi  ed in human cells by host cell reactivation assays in NHF, 
BS, and A-15 (corrected BS fi  broblasts) cells. Overexpression 
of RAD51 in NHF cells led to the expected increase in HR 
(Fig. 2 C). Conversely, overexpression of wild-type 53BP1 led 
to a four- to fi  vefold decrease in the rate of HR, confi  rming its 
antirecombinogenic role in human cells. Interestingly, over-
expression of wild-type 53BP1 in A-15 and BS cells cause a 
fourfold and twofold decrease, respectively. Hence, the inter-
action of BLM with 53BP1 was essential for the latter to attain 
its full antirecombinogenic potential.
To determine whether and, if so, how BLM and 53BP1 
together negatively regulate HR, we transfected BLM siRNA 
oligos into 53BP1
+/+ and 53BP1
−/− cells (Fig. S2 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200610051/DC1) and 
53BP1 siRNA oligos into BS/A-15 cells (Fig. 3 A). Western 
analysis revealed that both BLM and 53BP1 siRNAs were able 
to acutely down-regulate the expression of their cognate pro-
teins (Fig. 3 A and Fig. S2 A). Cells with both BLM and 53BP1 
expression (A-15 and 53BP1
+/+) exhibited low rates of HR, 
which increased 2–2.5-fold after replication arrest. BS cells or 
loss of BLM expression in 53BP1
+/+ cells led to an increase in 
the rate of HR. Loss of 53BP1 in either the mouse or human 
cells led to a HU-dependent increase in HR. In cells lacking the 
expression of both 53BP1 and BLM, the rate of HR increased 
synergistically in the presence of HU, thereby indicating that 
both BLM and 53BP1 together negatively regulated HR during 
replication arrest (Fig. 3 B and Fig. S2 B).
To further demonstrate that 53BP1 and BLM together reg-
ulate HR under physiological conditions, we needed to measure 
SCE in stable cell lines. 53BP1
+/+ and 53BP1
−/− cells could not 
be used, as stable lines expressing mouse BLM siRNA sequences 
could not be generated. Hence, the stable lines were derived 
from BS and A-15 cells by stable expression of human 53BP1 
siRNA (Fig. 3 C). BS cells exhibited a pronounced increase in 
both spontaneous and stress-induced SCE compared with A-15 
cells (Fig. 3 D). Loss of 53BP1 alone (A-15 53BP1
−/− cells) 
resulted in a three- to fourfold increase in SCE compared with 
A-15 only during HU treatment. However, BS 53BP1
−/− cells 
exhibit statistically signifi  cant synergistic increase in the stalled 
replication–induced SCE rate, indicating that 53BP1 negatively 
regulates HR during stalled replication both alone and in co-
operation with BLM. To determine how BLM and 53BP1 regulate 
HR, we hypothesized that the two proteins may be controlling 
RAD51 protein levels or its accumulation during HR. Although 
there was an increase in RAD51 protein level because of loss of 
BLM, there was no further change as a result of the subsequent 
loss of 53BP1 (Fig. S3 A, available at http://www.jcb.org/cgi/
content/full/jcb.200610051/DC1), indicating different modes 
of action of BLM and 53BP1 on RAD51 function.
RAD51 foci that are formed after stalled replication mark 
a subset of cells that have entered the HR pathway and contain 
functional recombination complexes (Raderschall et al., 1999). 
It is possible that BLM and/or 53BP1 affected the formation of 
Figure 3.  BLM and 53BP1 modulate HR and SCE. (A) Levels of 53BP1, 
BLM, and TBP in A-15 and BS cells with and without siRNA treatment. Nu-
clear extracts were prepared from HU-treated A-15 and BS cells. The cells 
were also transfected with 53BP1 siRNA. Single and double plus signs in-
dicate the ﬁ  rst and second round of siRNA transfection, respectively. West-
ern blots were performed with 25 μg of nuclear extracts and probed with 
anti-53BP1, anti-BLM, and anti-TBP antibodies. (B) Absence of 53BP1 and 
BLM negatively regulate HR. A-15 and BS cells were twice transfected with 
53BP1 siRNA in the presence of pBHRF. Before harvesting, the cells were 
either left untreated or treated with HU for 16 h. Cells were subsequently 
analyzed using a ﬂ  ow cytometer. The fold difference of the GFP/BFP ratio 
is represented. (C) Generation of BS 53BP1
−/− and A-15 53BP1
−/− stable 
isogenic cell lines. BS and A-15 cells were transfected with pSilencer2.1-
U6 hygro-53BP1. Cells stably expressing 53BP1 siRNA sequence were 
  selected with hygromycin. Two independent clones for both BS 53BP1
−/− 
and A-15 53BP1
−/− were analyzed for 53BP1 and actin levels. (D) Loss of 
both BLM and 53BP1 synergistically enhance SCE. SCE measurements 
(mean ± SD) were performed in A-15, BS, A-15 53BP1
−/− (clone 1), and 
BS 53BP1
−/− (clone 19) ﬁ   broblasts in the absence (−HU) or presence 
(+HU) of replication arrest. The p-values were obtained by t test.
Table I. Chromosomal abnormalities in 53BP1
+/+ and 53BP1
−/− cells
Abnormalities
a
Genotype Condition Breaks Gaps Rings Polyploidy Fragments Quadriradials Total
+/+ Control 0 1 0 6 13 0 20
HU 31 121 2 5 18 7 184
−/− Control 0 9 0 14 9 0 32
HU 72 418 0 10 54 44 598
P ≤ 0.001.
aNumbers indicate the total number of abnormalities scored in 100 metaphase cells.JCB • VOLUME 178 • NUMBER 1 • 2007  12
RAD51 foci. To investigate this possibility, BLM and/or 53BP1 
were transiently transfected into BS 53BP1
−/− cells and the 
rate of formation of endogenous RAD51 foci was determined. 
Transfection of either BLM or 53BP1 in HU-treated BS 53BP1
−/− 
cells resulted in a decrease in the number of RAD51 foci (Fig. S3, 
B and C). These results indicate that both BLM and 53BP1 may 
affect the formation of RAD51 nucleoprotein fi  laments and 
thereby negatively regulate HR.
Overexpression of RAD51 results in the formation of 
RAD51 nucleoprotein fi   laments reminiscent of presynaptic 
RAD51 complexes (Raderschall et al., 2002). Adenoviral over-
expression of RAD51 in HU-treated BS 53BP1
−/− cells resulted 
in a two- to threefold increase in the level of RAD51 protein 
(Fig. S3 D) and formation of high-order fi  lamentous nuclear 
structures up to 5 μm in length throughout the nuclei (Fig. 4 A 
and Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200610051/DC1). Around 80% of the cells infected with 
adenoviral RAD51 (Ad-RAD51) showed the appearance of these 
structures (Fig. 4, A and B). Overexpression of BLM or 53BP1 
decreased the number of cells with complete RAD51 structures, 
instead showing either disrupted structures or diffused RAD51 
staining (Fig. 4, A and B; and Videos 2 and 3). Both BLM and 
53BP1 colocalized with the disrupted RAD51 structures (Fig. 
4 C). Very few cells had RAD51 fi  laments when both 53BP1 
and BLM were overexpressed (Fig. 4 B). Hence, apart from 
the BLM-independent role, 53BP1 also cooperates with BLM 
to negatively regulate HR. It will be interesting to know the bio-
chemical parameters that govern the interactions among BLM, 
53BP1, and RAD51.
BLM is known to exert its antirecombinogenic functions 
in conjunction with other cellular proteins, like topoisomerase 
IIIα (Wu and Hickson, 2003). Additional interacting partners of 
sgs1 (the yeast orthologue of BLM) have been identifi  ed in 
large-scale genetic screens (Ooi et al., 2003). Deletion of RAD9 
(the yeast orthologue of 53BP1) alone was able to partially sup-
press the cell cycle arrest observed in sgs1 cells. Moreover, via-
bility of sgs1rad9 cells was reduced compared with their RAD9 
counterparts, consistent with the hypothesis that lack of sgs1 
creates DNA damage that is recognized by a RAD9-dependent 
checkpoint (McVey et al., 2001). More recently it was observed 
that SGS1 is critical for suppressing spontaneous translocations 
between highly diverged genes in cells mutated for RAD9 
(Schmidt et al., 2006). Hence, it is possible that in higher eukar-
yotes, BLM and 53BP1 can together maintain chromosomal in-
tegrity by modulating HR.
We hypothesize that BLM and 53BP1 may recognize dif-
ferent recombination substrates and thereby disrupt the RAD51 
fi  laments by different mechanisms. The disappearance of the 
fi  laments when BLM and 53BP1 are both expressed (Fig. 4 A) 
lends credence to this hypothesis. In vitro experiments have un-
masked a translocase activity for the yeast DNA helicase Srs2, 
which is involved in disrupting the RAD51 nucleofi  lament 
(Veaute et al., 2003). It is possible that a similar mechanism 
may exist for BLM. Our data also provides a logical explana-
tion for the reported physical interaction of BLM with RAD51 
(Wu et al., 2001). This mechanism possibly occurs parallel to 
the reported ability of BLM and topoisomerase IIIα to resolve 
recombination intermediates like double Holliday junctions 
into noncrossover products (Wu and Hickson, 2003). The pres-
ence of multiple mechanisms may be required for effecting ex-
act control of RAD51 function.
Recent studies have demonstrated that signal transducer 
proteins can have other functions in addition to their known 
roles in the transmission of DNA damage signal. Like 53BP1, 
mediator of DNA damage checkpoint protein (MDC1) and breast 
cancer type 1 susceptibility gene 1 (BRCA1) are also known 
to participate in DNA damage sensing and signaling pathways, 
particularly in S-phase (Scully et al., 1997; Lou et al., 2003). 
Figure 4.  BLM and 53BP1 inhibit RAD51 nucleoprotein ﬁ  lament formation. 
(A) BLM and 53BP1 inhibit RAD51 polymerization. BS 53BP1
−/− (clone 19) 
cells were transfected with vector, BLM, 53BP1, or BLM+ 53BP1 and sub-
sequently infected with Ad-RAD51. The percentage of cells positive for 
RAD51 expression was  20–25%. Immunoﬂ  uorescence was performed 
with anti-RAD51 antibodies, and two cells representing the majority staining 
pattern are represented for each type of transfection/infection. (B) Quanti-
tation of A. (C) BLM and 53BP1 colocalize with RAD51 on nucleoprotein 
ﬁ  laments. Experiments were done as in A. Immunoﬂ  uorescence was per-
formed with anti-RAD51–BLM (top) and anti-RAD51–53BP1 (bottom) anti-
bodies. Bars, 5 μm.53BP1 AND BLM EFFECT ON RECOMBINATION • TRIPATHI ET AL. 13
Although 53BP1 has an antirecombinogenic function on HR 
(Adams et al., 2005; this work), MDC1 interacts with RAD51 
and facilitates HR in response to IR (Zhang et al., 2005). 
BRCA1 decreases spontaneous HR and gene conversion and 
deletion events without affecting recombination intermediates, 
but it also promotes HR repair of chromosomal double-strand 
breaks and activates RAD51 function (Cousineau et al., 2005). 
This effect on HR by BRCT (C-terminal domain of BRCA1 
protein BRCT)–containing adaptor proteins may be modulated 
by the presence of specifi  c domains (like Tudor domain for 
53BP1 or forkhead-associated domain of MDC1) and their in-
teracting partners.
The observations that transducer proteins, like BLM and 
53BP1, function in HR can have important implications in our 
understanding the pathway of DNA damage response. Because 
lack of BLM leads to almost all kinds of cancer in human 
and mouse models (Hickson, 2003), BLM is probably at the 
center of such a DNA damage signal transmission highway. 
BLM may obtain the signal upstream kinases (Davies et al., 
2004;   Sengupta et al., 2004) and, depending on the type and 
extent of damage, transmits the signal to repair pathways like 
HR and simultaneously synergizes with its interacting partners 
(like p53 and 53BP1; Sengupta et al., 2003; this work) to en-
sure that the extent of recombination is exact. BLM takes into 
account the antirecombinogenic role of 53BP1, enhancing its 
interaction with RAD51. Subsequently, the two antirecombino-
genic proteins modulate RAD51 function, with 53BP1 proba-
bly acting as a backup for BLM. The fact that 53BP1 is required 
for effi  cient accumulation of BLM to the sites of stalled replication 
(Sengupta et al., 2004), and BLM in turn enhances the 53BP1–
RAD51 interaction, suggests the presence of a feed-forward 
system involved in effi  cient recognition, transmission, and res-
olution of the DNA damage.
Materials and methods
Plasmids
pCMH6K53BP1 was a gift from K. Iwabuchi (Kanazawa Medical Univer-
sity, Ishikawa, Japan). pSilencer2.1-U6 hygro-53BP1 was obtained by 
cloning the 19-nucleotide 53BP1 siRNA sequence G  A  A  C  G  A  G  G  A  G  A  C  G-
G  T  A  A  T  A   into the BamHI–HindIII sites of pSilencer2.1-U6 hygro (Ambion).
Antibodies
The following antibodies were used: anti-BLM goat polyclonal C- 18 (Santa 
Cruz Biotechnology, Inc.; Western blots and immunoﬂ  uorescence), anti-BLM 
rabbit polyclonal (Novus; IPs), anti-53BP1 mAb (BD Biosciences; immuno-
ﬂ  uorescence), anti-53BP1 rabbit polyclonal (a gift from Y. Adachi, University of 
Edinburgh, Edinburgh, UK; Western blots and IPs), anti-TBP mAb l 58C9 (Santa 
Cruz Biotechnology, Inc.), anti-RAD51 rabbit polyclonal Ab-1 (Calbiochem), 
and anti-actin mAb C-2 (Santa Cruz Biotechnology, Inc.). Secondary anti-
bodies were purchased from Jackson ImmunoResearch Laboratories and 
Southern Biotechnology Associates, Inc.
Cells, culture conditions, and treatments
hTERT-immortalized BS ﬁ  broblasts, BS cells, and the corrected BS ﬁ  broblasts 
A-15 were a gift from J. Shay (University of Texas Southwestern Medical 
Center, Dallas, TX). Wild-type and knockout primary 53BP1 mouse embry-
onic ﬁ  broblasts were a gift from J. Chen (Yale University School of Medicine, 
New Haven, CT). All of the above cell lines, along with the hTERT-immortalized 
NHF strain GM07532 (NHF), were maintained as described previously 
(Sengupta et al., 2003, 2004). 1 mM HU (Sigma-Aldrich) treatments were 
done as described previously (Sengupta et al., 2003). Cells were either 
left untreated (–HU) or treated (+HU) for 16 h. Parallel HU-treated plates 
were washed, and incubation was continued for a further 6 h (postwash). 
To generate BS 53BP1
−/− and A-15 53BP1
−/− stable cell lines, the parental 
BS and A-15 cells were transfected with pSilencer2.1-U6 hygro-53BP1 plasmid. 
Standard procedures were followed to select stably transfected cells express-
ing 53BP1 siRNA with 50 μg/ml hygromycin B.
Microscopy
Immunoﬂ  uorescence was performed as described previously (Sengupta 
et al., 2003). Cells were ﬁ  xed, and the stained cells were visualized in a 
motorized epiﬂ  uorescence microscope (Upright Axioimager M1; Carl Zeiss 
MicroImaging, Inc.) equipped with a high-resolution camera (AxioCam 
MRm Rev. 2; Carl Zeiss MicroImaging, Inc.). Images were analyzed by 
AxioVision Software Rel. 4.4 (Carl Zeiss MicroImaging, Inc.). The images 
were taken with Plan Apochromat objective 100×/1.40 oil immersion 
using FITC or Texas red ﬂ  uorophore. At least 100 cells were analyzed for 
a colocalization experiment. The images were subsequently imported into 
Canvas graphics software, where adjustments were made for the whole 
image for brightness, contrast, and color balance.
Plasmid and siRNA transfections
Based on two published sequences (DiTullio et al., 2002; Kao et al., 2003), 
siRNAs for 53BP1 were synthesized by Dharmacon. Both the siRNA 
sequences were alternately used and gave the same results. Commercially 
available mouse BLM siRNA was purchased from Santa Cruz Biotechnology, 
Inc. Scrambled duplex RNA and luciferase siRNA (Dharmacon) were used 
as controls.
All transfections were done using Lipofectamine 2000 (Invitrogen). 
For HR assay, transfection was done either for HR substrate (pBHRF) alone 
or pBHRF combination with siRNAs. Cells transfected with pBHRF were 
grown for 24 h followed by 16 h of HU treatment. Transfections involving 
siRNA oligos were done twice. After the second round, the cells were 
grown for 24 h and treated with HU for 16 h. Each experiment was done 
in triplicate and repeated three times. Cells were subsequently treated for 
Western blotting or ﬂ  ow cytometry.
Flow cytometry and host cell reactivation assay
Cells were ﬁ  xed for ﬂ  ow cytometry according to standard protocols. Cells 
were analyzed using a ﬂ  ow cytometer (BD LSR; BD Biosciences) for both 
cell cycle analysis and host cell reactivation assay. The host cell reactiva-
tion assay to determine HR rate was performed as described previously 
(Slebos and Taylor, 2001). Transfections were performed with the sub-
strate (pBHRF), encoding an intact, emission-shifted, “blue” variant of GFP 
(BFP), with a 300-nucleotide stretch of homology to a nonfunctional copy 
of GFP. In the absence of HR, only BFP is present, whereas HR can also 
create a functional GFP.
Clonogenic assays
53BP1
+/+ and 53BP1
−/− cells were plated out at low dilutions and treated 
with different concentrations of HU, and the treatment was continued for 
48 h. After removal of the drug-treated medium, the cells were washed and 
subsequently allowed to grow in complete growth medium undisturbed 
for 14 d. The colonies formed were ﬁ  xed and subsequently stained with 
Giemsa. The whole experiment was done twice in triplicates, and the data 
shown are cumulative of both experiments.
SCE analysis and chromosomal aberration studies
SCE analysis for –HU cultures was performed according to standard proto-
cols. For +HU cultures, BrdU-treated cells were cotreated with HU for 16 h 
during the second round of DNA duplication. The cells arrested in S-phase 
were subsequently washed, and incubation was continued in the presence 
of BrDU for a further 8 h before colcemid treatment. 25 metaphase spreads 
were imaged at 100× in a microscope (Axioimager M1) for each cell line. 
The whole experiment was performed twice, and for each cell line, SCE 
was scored blind. The p-values were obtained by t test. The conditions are 
two-tailed, unpaired data with unequal variance.
For study of chromosomal aberrations, 100 well-spread metaphase 
cells, stained with 4% Gurr’s Giemsa solution from four independent exper-
iments were examined at in a microscope (Axioimager M1) with 100× 
objective. Standard criteria were chosen for each chromosomal   aberration. 
The total frequencies of abnormalities were compared with the control group 
to obtain the p-value.
In vivo RAD51 polymerization assay
BS 53BP1
−/− cells were transfected with either BLM or 53BP1. 6 h after 
transfection, the cells were infected with replication-defective adenoviral 
genomes generated as described previously (Sengupta et al., 2003). 34 h 
after infection, the cells were treated with HU, and the incubation was JCB • VOLUME 178 • NUMBER 1 • 2007  14
continued for a further 16 h. The cells were washed and ﬁ  xed for immuno-
ﬂ  uorescence. The experiments were repeated thrice, and a total of 150 
cells showing RAD51 expression were counted.
Online supplemental material
Fig. S1 shows cell cycle analysis and nucleocytoplasmic separation of 
NHFs grown under different conditions. Fig. S2 show that 53BP1 and 
BLM together modulate HR in mouse cells. Fig. S3 shows that 53BP1 
and BLM regulate RAD51 foci formation. Video 1 shows visualization of 
RAD51 ﬁ  laments. Video 2 shows visualization of the disruption of RAD51 
ﬁ  laments as a result of BLM overexpression. Video 3 shows visualization 
of the disruption of RAD51 ﬁ  laments as a result of 53BP1 overexpression. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200610051/DC1.
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